Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Okafor, Christian MF
Anumudu, Chiaka I
Omosun, Yusuf O
Uthaipibull, Chairat
Ayede, Idowu
Awobode, Henrietta O
Odaibo, Alex B
Langhorne, Jean
Holder, Anthony A
Nwuba, Roseangela I
and
Troye-Blomberg, Marita
2009.
Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.
Malaria Journal,
Vol. 8,
Issue. 1,
Hinds, Louise
Green, Judith L.
Knuepfer, Ellen
Grainger, Munira
and
Holder, Anthony A.
2009.
Novel Putative Glycosylphosphatidylinositol-Anchored Micronemal Antigen of
Plasmodium falciparum
That Binds to Erythrocytes
.
Eukaryotic Cell,
Vol. 8,
Issue. 12,
p.
1869.
Holder, Anthony A.
and
Rall, Glenn F.
2009.
Malaria Vaccines: Where Next?.
PLoS Pathogens,
Vol. 5,
Issue. 10,
p.
e1000638.
Lazarou, Maria
Patiño, José A. Guevara
Jennings, Richard M.
McIntosh, Richard S.
Shi, Jianguo
Howell, Steven
Cullen, Eilish
Jones, Tarran
Adame-Gallegos, Jaime R.
Chappel, Jonathan A.
McBride, Jana S.
Blackman, Michael J.
Holder, Anthony A.
and
Pleass, Richard J.
2009.
Inhibition of Erythrocyte Invasion andPlasmodium falciparumMerozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 Antibodies.
Infection and Immunity,
Vol. 77,
Issue. 12,
p.
5659.
Kadekoppala, Madhusudan
and
Holder, Anthony A.
2010.
Merozoite surface proteins of the malaria parasite: The MSP1 complex and the MSP7 family.
International Journal for Parasitology,
Vol. 40,
Issue. 10,
p.
1155.
Ngoundou-Landji, Josiane
Nwuba, Roseangela I
Anumudu, Chiaka I
Odaibo, Alexander B
Matondo Maya, Wenceslas D
Awobode, Henrietta O
Okafor, Christian M
Morenikeji, Olajumoke A
Asinobi, Adanze
Nwagwu, Mark
Holder, Anthony A
and
Ntoumi, Francine
2010.
Fine specificity of anti-MSP119 antibodies and multiplicity of Plasmodium falciparum Merozoite Surface Protein 1 types in individuals in Nigeria with sub-microscopic infection.
Malaria Journal,
Vol. 9,
Issue. 1,
Boyle, Michelle J.
Wilson, Danny W.
Richards, Jack S.
Riglar, David T.
Tetteh, Kevin K. A.
Conway, David J.
Ralph, Stuart A.
Baum, Jake
and
Beeson, James G.
2010.
Isolation of viable
Plasmodium falciparum
merozoites to define erythrocyte invasion events and advance vaccine and drug development
.
Proceedings of the National Academy of Sciences,
Vol. 107,
Issue. 32,
p.
14378.
Goodman, Anna L.
Epp, C.
Moss, D.
Holder, A. A.
Wilson, J. M.
Gao, G. P.
Long, C. A.
Remarque, E. J.
Thomas, A. W.
Ammendola, V.
Colloca, S.
Dicks, M. D. J.
Biswas, S.
Seibel, D.
van Duivenvoorde, L. M.
Gilbert, S. C.
Hill, A. V. S.
and
Draper, S. J.
2010.
New Candidate Vaccines against Blood-StagePlasmodium falciparumMalaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1.
Infection and Immunity,
Vol. 78,
Issue. 11,
p.
4601.
Goodman, A. L.
and
Draper, S. J.
2010.
Blood-stage malaria vaccines — recent progress and future challenges.
Annals of Tropical Medicine & Parasitology,
Vol. 104,
Issue. 3,
p.
189.
Child, Matthew A.
Epp, Christian
Bujard, Hermann
and
Blackman, Michael J.
2010.
Regulated maturation of malaria merozoite surface protein‐1 is essential for parasite growth.
Molecular Microbiology,
Vol. 78,
Issue. 1,
p.
187.
Draper, Simon J.
Biswas, Sumi
Spencer, Alexandra J.
Remarque, Edmond J.
Capone, Stefania
Naddeo, Mariarosaria
Dicks, Matthew D. J.
Faber, Bart W.
de Cassan, Simone C.
Folgori, Antonella
Nicosia, Alfredo
Gilbert, Sarah C.
and
Hill, Adrian V. S.
2010.
Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines.
The Journal of Immunology,
Vol. 185,
Issue. 12,
p.
7583.
Miller, Martin R.
Råberg, Lars
Read, Andrew F.
Savill, Nicholas J.
and
Tanaka, Mark M.
2010.
Quantitative Analysis of Immune Response and Erythropoiesis during Rodent Malarial Infection.
PLoS Computational Biology,
Vol. 6,
Issue. 9,
p.
e1000946.
Patarroyo, Manuel E.
Cifuentes, Gladys
Piraján, Camilo
Moreno-Vranich, Armando
and
Vanegas, Magnolia
2010.
Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.
Biochemical and Biophysical Research Communications,
Vol. 394,
Issue. 3,
p.
529.
Lau, On Sun
Ng, Danny W.-K.
Chan, Wendy W.L.
Chang, Sandra P.
and
Sun, Samuel S.M.
2010.
Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds.
Plant Biotechnology Journal,
Vol. 8,
Issue. 9,
p.
994.
Bargieri, Daniel Y.
Leite, Juliana A.
Lopes, Stefanie C.P.
Sbrogio-Almeida, Maria Elisabete
Braga, Catarina J.M.
Ferreira, Luis C.S.
Soares, Irene S.
Costa, Fabio T.M.
and
Rodrigues, Mauricio M.
2010.
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium.
Vaccine,
Vol. 28,
Issue. 16,
p.
2818.
Douglas, Alexander D.
Williams, Andrew R.
Illingworth, Joseph J.
Kamuyu, Gathoni
Biswas, Sumi
Goodman, Anna L.
Wyllie, David H.
Crosnier, Cécile
Miura, Kazutoyo
Wright, Gavin J.
Long, Carole A.
Osier, Faith H.
Marsh, Kevin
Turner, Alison V.
Hill, Adrian V.S.
and
Draper, Simon J.
2011.
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Nature Communications,
Vol. 2,
Issue. 1,
Sheehy, Susanne H
Duncan, Christopher JA
Elias, Sean C
Collins, Katharine A
Ewer, Katie J
Spencer, Alexandra J
Williams, Andrew R
Halstead, Fenella D
Moretz, Samuel E
Miura, Kazutoyo
Epp, Christian
Dicks, Matthew DJ
Poulton, Ian D
Lawrie, Alison M
Berrie, Eleanor
Moyle, Sarah
Long, Carole A
Colloca, Stefano
Cortese, Riccardo
Gilbert, Sarah C
Nicosia, Alfredo
Hill, Adrian VS
and
Draper, Simon J
2011.
Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors.
Molecular Therapy,
Vol. 19,
Issue. 12,
p.
2269.
Bisseye, C
Yindom, L M
Simporé, J
Morgan, W D
Holder, A A
and
Ismaili, J
2011.
An engineeredPlasmodium falciparumC-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.
Clinical and Experimental Immunology,
Vol. 166,
Issue. 3,
p.
366.
Olivieri, Anna
Collins, Christine R.
Hackett, Fiona
Withers-Martinez, Chrislaine
Marshall, Joshua
Flynn, Helen R.
Skehel, J. Mark
Blackman, Michael J.
and
Carruthers, Vern B.
2011.
Juxtamembrane Shedding of Plasmodium falciparum AMA1 Is Sequence Independent and Essential, and Helps Evade Invasion-Inhibitory Antibodies.
PLoS Pathogens,
Vol. 7,
Issue. 12,
p.
e1002448.
Brito, Cristiana Ferreira Alves de
and
Ferreira, Marcelo Urbano
2011.
Molecular markers and genetic diversity of Plasmodium vivax.
Memórias do Instituto Oswaldo Cruz,
Vol. 106,
Issue. suppl 1,
p.
12.